State of Wyoming’s Collegium Pharmaceutical COLL Stock Holding History

State of Wyoming’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Sell	6,035 -3,179	-35%	-$109K	0.02%	949
2026 Q1	$305K	Buy	9,214 +3,965	+76%	+$168K	0.04%	661
2025 Q4	$243K	Sell	5,249 -2,597	-33%	-$109K	0.03%	829
2025 Q3	$275K	Sell	7,846 -4,451	-36%	-$155K	0.03%	740
2025 Q2	$364K	Buy	12,297 +6,547	+114%	+$187K	0.04%	514
2025 Q1	$172K	Sell	5,750 -4,068	-41%	-$124K	0.02%	901
2024 Q4	$281K	Buy	9,818 +4,208	+75%	+$139K	0.04%	603
2024 Q3	$217K	Buy	+5,610	New	+$200K	0.03%	650
2023 Q3	–	Sell	-2,389	Closed	-$51.3K	–	1664
2023 Q2	$51.3K	Sell	2,389 -1,119	-32%	-$25.4K	0.02%	1149
2023 Q1	$84.2K	Buy	3,508 +128	+4%	+$3.39K	0.03%	873
2022 Q4	$78.4K	Sell	3,380 -4,941	-59%	-$99.6K	0.03%	891
2022 Q3	$133K	Buy	8,321 +677	+9%	+$11.9K	0.07%	428
2022 Q2	$135K	Buy	7,644 +5,138	+205%	+$86.4K	0.08%	309
2022 Q1	$51K	Sell	2,506 -1,013	-29%	-$19.1K	0.03%	1042
2021 Q4	$66K	Buy	+3,519	New	+$68.6K	0.03%	941

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

State of Wyoming's COLL Position: Q2 2026 in Review

State of Wyoming reduced its Collegium Pharmaceutical (COLL) stake by 35% in Q2 2026, selling an estimated $109K and leaving 6,035 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #949.

State of Wyoming first reported a position in COLL in Q4 2021 and has held it in 15 quarters since. The position peaked at $364K in Q2 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

State of Wyoming held 6,035 shares of Collegium Pharmaceutical worth $218K as of Q2 2026.
State of Wyoming sold 3,179 Collegium Pharmaceutical shares in Q2 2026, an estimated $109K.
Collegium Pharmaceutical made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #949 holding.
State of Wyoming first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 15 quarters since.
State of Wyoming's Collegium Pharmaceutical position peaked at $364K in Q2 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.